Alimentary Pharmacology & Therapeutics, 0269-2813

Journal

1 - 10 out of 56Page size: 10

Publications

  1. 2020
  2. Accepted/In press

    Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018

    Raoul Reulen, Rasiah Thayakaran, Anuradhaa Subramanian, Krishna Gokhale, Krishnarajah Nirantharakumar, Nicola Adderley, 9 Mar 2020, (Accepted/In press) In : Alimentary Pharmacology & Therapeutics.

    Research output: Contribution to journal › Article

  3. 2019
  4. Published

    Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?

    Mohammed Nabil Quraishi, 1 Sep 2019, In : Alimentary Pharmacology & Therapeutics. 50, 5, p. 605-606

    Research output: Contribution to journal › Article

  5. Published

    Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease

    Uday Shivaji, Marietta Iacucci, Subrata Ghosh, 1 Mar 2019, In : Alimentary Pharmacology & Therapeutics. 49, 6, p. 664-680 17 p.

    Research output: Contribution to journal › Review article

  6. 2018
  7. Published

    The impact of ileal-pouch anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis

    Palak Trivedi, Richard Laing, Thomas Pinkney, Gideon Hirschfield, Tariq Iqbal, 11 Jul 2018, In : Alimentary Pharmacology & Therapeutics. 48, 3

    Research output: Contribution to journal › Article

  8. Published

    Letter: unlikely liver bedfellows—alpha-1 antitrypsin deficiency and granulomatosis with polyangiitis. Author's reply

    Alice Turner, Jul 2018, In : Alimentary Pharmacology and Therapeutics. 48, 2, 1 p.

    Research output: Contribution to journal › Letter

  9. Published

    Long-term efficacy and safety of ustekinumab for Crohn’s disease through the second year of therapy

    Subrata Ghosh, Jul 2018, In : Alimentary Pharmacology & Therapeutics. 48, 1, p. 65-77 13 p.

    Research output: Contribution to journal › Article

  10. E-pub ahead of print

    Review article: novel oral-targeted therapies in inflammatory bowel disease

    Subrata Ghosh & Marietta Iacucci, 19 Apr 2018, In : Alimentary Pharmacology & Therapeutics. 13 p.

    Research output: Contribution to journal › Article

  11. Published

    Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study

    Gwilym Webb & Gideon Hirschfield, 1 Apr 2018, In : Alimentary Pharmacology & Therapeutics. 47, 8, p. 1213-1219

    Research output: Contribution to journal › Article

  12. Published

    Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease

    Sarah Townsend, Paul Ellis, Philip Newsome & Alice Turner, Apr 2018, In : Alimentary Pharmacology & Therapeutics. 47, 7, p. 877-885 9 p.

    Research output: Contribution to journal › Article

  13. Published

    Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease

    Gideon Hirschfield, Mar 2018, In : Alimentary Pharmacology & Therapeutics. 47, 5, p. 631-644 14 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 Next